The merger between London Stock Exchange and Borsa Italiana in 2007 created Europe’s leading Exchange Group, representing:
Europe is an incredibly diverse region in terms of culture and entrepreneurial models. And London, with its uniquely international profile, is uniquely placed to capture and valorise these differences.
A London listing offers access to a truly global community with a deep understanding of international companies. As a team we are entirely dedicated to maximising our client’s exposure, bringing together both investors and issuers at industry events such as our Capital Market Days.
In recent years London Stock Exchange has become the leading listing venue for companies in Europe. It is now home to about 150 companies from across Europe, representing a collective market capitalisation of close to £500 bn.
The latest listings cover a diverse range of industry sectors including technology, industrial, energy, real-estate, consumer goods, PE/VC backed and investment funds.
We regularly visit countries across Europe, attending conferences, round tables, seminars and private meetings. If you’re considering raising capital now or in the future and would like to know more, we can help.
London Stock Exchange today welcomes MGC Pharmaceuticals ("MGC Pharma" or the "Company") (LSE, ASX: MXC), a Bio-Pharma company with a “Nature to Medicine” strategy at the forefront of the emerging global phytocannabinoid derived medicines looking on the London Main Market Listing. MGC Pharma is the first medicinal cannabis related company to join the Main Market of the bourse.
London Stock Exchange today welcomes Intuitive Investments Group plc (‘Intuitive’, the ‘Company’ or ‘Group’), an investing company focussed on gaining exposure to Life Sciences businesses, to celebrate the listing of the Company's public shares onto AIM, under the ticker "IIG".
The Company is a newly established investing company, seeking to provide investors in the Company with expos
London Stock Exchange today welcomes HeiQ Plc (LSE: HEIQ) to trading on the Main Market.
HeiQ is a global, profitable pioneer in the $24 billion textile chemicals market, directly serving the $10 billion antimicrobial textile market with its recent Swiss Technology Award-winning HeiQ Viroblock technology. Founded in 2005, HeiQ has grown into a high growth, cash generative compan
Head of Europe, Primary Markets, London Stock Exchange plc
Head of Central and Southern Europe, London Stock Exchange plc
Western Europe Business Development Manager, Primary Markets, London Stock Exchange plc